Curaleaf (OTCMKTS:CURLF) Trading Down 6.8% - Here's Why

Key Points

• Curaleaf shares fell about 6.8% intraday to roughly $2.22–$2.255, with trading volume around 601,954 shares, about 32% below the average daily volume.
• Analyst sentiment is positive overall — the stock carries an average rating of "Buy" (two Strong Buy, one Buy, one Hold), with Zacks raising its rating to Hold and Alliance Global Partners reaffirming a Buy.
• The company beat the latest quarter's estimates (EPS of -$0.05 vs. -$0.08 expected; revenue $333.07M vs. $328.7M expected) but remains unprofitable with a negative net margin (~-18.1%) and analysts forecast FY EPS of about -$0.25.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) shares were down 6.8% during mid-day trading on Tuesday . The stock traded as low as $2.22 and last traded at $2.2550. Approximately 601,954 shares were traded during mid-day trading, a decline of 32% from the average daily volume of 884,387 shares. The stock had previously closed at $2.42.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CURLF shares. Zacks Research raised shares of Curaleaf from a "strong sell" rating to a "hold" rating in a research report on Thursday, January 1st. Alliance Global Partners reaffirmed a "buy" rating on shares of Curaleaf in a research report on Monday, December 22nd. Two analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Buy".

Curaleaf Trading Down 6.6%

The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of -7.53 and a beta of 0.77. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.52 and a quick ratio of 0.76. The business's 50-day simple moving average is $2.31 and its two-hundred day simple moving average is $2.59.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.08) by $0.03. The firm had revenue of $333.07 million for the quarter, compared to analysts' expectations of $328.70 million. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 23.17%. On average, research analysts anticipate that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company's vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf's product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.